As the most effective and economical means to prevent and control the infection of the SARS-CoV-2, the R&D and application of the COVID-19 vaccine have always attracted much attention. The development of the COVID-19 vaccine has applied a variety of technical routes, namely inactivated vaccines, recombinant protein vaccines, adenovirus vector vaccines, attenuated influenza virus vector vaccines, and nucleic acid vaccines.